Repligen reported $60.44M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agilent A:US $ 435M 40M
Align Technology ALGN:US $ 272.03M 64.35M
Biomarin Pharmaceutical BMRN:US $ 41.16M 14.24M
Bristol Myers Squibb BMY:US $ 5679M 455M
Bruker BRKR:US $ 111.2M 4.2M
Catalent CTLT:US $ 326.3M 57.5M
Charles River Laboratories CRL:US $ 209.66M 23.6M
Danaher DHR:US $ 2530M 31M
Dentsply International XRAY:US 250M 5M
Fluidigm FLDM:US $ -13.15M 2.04M
General Electric GE:US $ 1529M 118M
Henry Schein HSIC:US $ 260.86M 21.36M
Illumina ILMN:US $ 236M 5M
IQVIA Holdings Inc IQV:US $ 648M 26M
Luminex LMNX:US $ 21.3M 3.09M
Mettler Toledo International MTD:US 269.24M 45.51M
Myriad Genetics MYGN:US $ -2.1M 26.2M
Nanostring Technologies NSTG:US $ -24.2M 0.23M
Patterson Companies PDCO:US $ 68.56M 10.68M
Peregrine Pharmaceuticals PPHM:US $ 7.94M 3.85M
Perkinelmer PKI:US $ 398.96M 158.86M
Pfizer PFE:US $ 7593M 610M
Repligen RGEN:US $ 60.44M 10.97M
Thermo Fisher Scientific TMO:US $ 2942M 766M
Waters WAT:US $ 229.24M 26.61M
West Pharmaceutical Services WST:US $ 238.7M 33M